Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia. The discovery could lead to breakthrough therapies for sickle cell disease and thalassemia, which could potentially eliminate the devastating and life-threatening complications of these diseases, such as severe pain, damage to the eyes and other organs, infections, and stroke.
- Researchers find new genetic target for sickle cell disease therapyThu, 4 Dec 2008, 14:37:25 EST
- Gaining ground on sickle cell diseaseTue, 15 Jul 2008, 17:07:57 EDT
- Modulator of fetal hemoglobin switch may target sickle cell diseaseMon, 12 Jul 2010, 12:23:25 EDT
- Correcting sickle cell disease with stem cellsWed, 28 Sep 2011, 22:35:43 EDT
- Acute anemia linked to silent strokes in childrenFri, 11 Feb 2011, 13:37:06 EST